American Heart Association

Cutting Daily Sodium Intake Significantly Lowers Blood Pressure in 1 Week, According to New Research

Systolic BP Target of <120 mm Hg Reduces CV Event Risk, According to New Data from AHA Scientific Sessions 2023

Social Vulnerabilities Linked to Cardiometabolic Risk in Pregnant Women in US, New Study Finds

Sotagliflozin Cuts Risk by >50% for Heart Failure Readmission, CV Death in Phase 3 SOLOIST-WHF Trial

Study: “Worrisome” Changes in Cardiovascular Function Immediately after Vaping, Smoking Traditional Cigarettes

Wearable Device Uptake Low Among Adults with Cardiovascular Disease, Nationally Representative Study Finds

Perceived Discrimination Impairs Post-MI Recovery in Young Adults, Study Warns

Oral PCSK9 Inhibitor Significantly Reduced High Levels of Cholesterol in Phase 1 Trials

First Sign of CVD in Smokers May be a Fatal MI or Stroke, New Study Finds

Canagliflozin Improved HF Symptoms, QOL Regardless of Diabetes Status in Fully Remote Clinical Trial

Remote Program Improves Blood Pressure and Cholesterol in High-risk Patients

Gregory Marcus, MD, MAS, Reviews the Coffee and Real-time Atrial & Ventricular Ectopy (CRAVE) Trial

AHA 2021: Novel Fitbit Algorithm Correctly Detected Undiagnosed Atrial Fibrillation

Coffee Had Negligible Effect on Atrial Arrhythmias but Was Linked to PVCs, Study Finds

Population for Digital Heart Failure Coaching App May Need Rethinking

Study Highlights Factors that Influence Patient Engagement with Remote CVD Risk Reduction Intervention

EHR-integrated Remote Monitoring of Hypertension: A Pilot Study in Primary Care

Automated Statin-associated Muscle Symptom Tracker May Help Tailor Therapy, Improve Adherence

Effective BP Reduction Achieved via Hypertension Remote Care Program During Lockdown

Living in More Socially Vulnerable Neighborhood Linked to Worse Outcomes in Hospitalized COVID-19 Patients

Risk of Early Stroke Increased in Adults who Vape vs Smoke Traditional Cigarettes, Study Finds

Young Black Adults Experienced Rising Burden of CVD Risk Factors, Worse Hospital Outcomes in 10-year Study